IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v131y2015icp305-312.html
   My bibliography  Save this article

Growth hormone, enhancement and the pharmaceuticalisation of short stature

Author

Listed:
  • Morrison, Michael

Abstract

This paper takes the biological drug human Growth Hormone (hGH) as a case study to investigate processes of pharmaceuticalisation and medicalisation in configuring childhood short stature as a site for pharmaceutical intervention. Human growth hormone is considered to have legitimate applications in treating childhood growth hormone deficiency and short stature associated with other recognised conditions. It is also regarded by bioethicists and others as a form of human biomedical enhancement when applied to children with idiopathic or ‘normal’ short stature. The purpose of this study is not to evaluate whether treatment of idiopathic short stature is enhancement or not, but to evaluate how some applications of hGH in treating short stature have come to be accepted and stabilised as legitimate ‘therapies’ while others remain contested as ‘enhancements’. A comparative, historical approach is employed, drawing on approaches from medical sociology and Science and Technology Studies (STS) to set out a socio-technical history of hGH in the US and UK. Through this history the relative influence and interplay of drivers of pharmaceuticalisation, including industry marketing and networks of drug distribution, and processes of medicalisation will be employed to address this question and simultaneously query the value of enhancement as a sociological concept.

Suggested Citation

  • Morrison, Michael, 2015. "Growth hormone, enhancement and the pharmaceuticalisation of short stature," Social Science & Medicine, Elsevier, vol. 131(C), pages 305-312.
    • Handle: RePEc:eee:socmed:v:131:y:2015:i:c:p:305-312
    DOI: 10.1016/j.socscimed.2014.10.015
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953614006613
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.socscimed.2014.10.015?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Bell, Susan E. & Figert, Anne E., 2012. "Medicalization and pharmaceuticalization at the intersections: Looking backward, sideways and forward," Social Science & Medicine, Elsevier, vol. 75(5), pages 775-783.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Diogo Silva da Cunha & Hélder Raposo, 2022. "A New Time of Reckoning, a Time for New Reckoning: Views on Health and Society, Tensions between Medicine and the Social Sciences, and the Process of Medicalization," Societies, MDPI, vol. 12(4), pages 1-51, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Dew, Kevin & Norris, Pauline & Gabe, Jonathan & Chamberlain, Kerry & Hodgetts, Darrin, 2015. "Moral discourses and pharmaceuticalised governance in households," Social Science & Medicine, Elsevier, vol. 131(C), pages 272-279.
    2. Başaran, Oyman, 2020. "“The self-making of the scientific circumciser (fenni sünnetçi):” the medicalization of male circumcision in Turkey," Social Science & Medicine, Elsevier, vol. 265(C).
    3. Mamo, Laura & Epstein, Steven, 2014. "The pharmaceuticalization of sexual risk: Vaccine development and the new politics of cancer prevention," Social Science & Medicine, Elsevier, vol. 101(C), pages 155-165.
    4. Terrence D. Hill & Jason A. Ford & Harvey L. Nicholson, 2022. "Education and polypharmacy: A national study of racial and ethnic variations," Social Science Quarterly, Southwestern Social Science Association, vol. 103(7), pages 1687-1705, December.
    5. Sariola, Salla & Ravindran, Deapica & Kumar, Anand & Jeffery, Roger, 2015. "Big-pharmaceuticalisation: Clinical trials and Contract Research Organisations in India," Social Science & Medicine, Elsevier, vol. 131(C), pages 239-246.
    6. Blumenstock, Shari M. & Papp, Lauren M., 2021. "Substance use behaviors in the daily lives of U.S. college students reporting recent use: The varying roles of romantic relationships," Social Science & Medicine, Elsevier, vol. 279(C).
    7. Arribas-Ayllon, Michael, 2016. "After geneticization," Social Science & Medicine, Elsevier, vol. 159(C), pages 132-139.
    8. Chabrol, Fanny & David, Pierre-Marie & Krikorian, Gaëlle, 2017. "Rationing hepatitis C treatment in the context of austerity policies in France and Cameroon: A transnational perspective on the pharmaceuticalization of healthcare systems," Social Science & Medicine, Elsevier, vol. 187(C), pages 243-250.
    9. Slagboom, M. Nienke & Bröer, Christian & Berg, Jonathan, 2021. "Negotiating ADHD: Pragmatic medicalization and creolization in urban India," Social Science & Medicine, Elsevier, vol. 289(C).
    10. Vrecko, Scott, 2015. "Everyday drug diversions: A qualitative study of the illicit exchange and non-medical use of prescription stimulants on a university campus," Social Science & Medicine, Elsevier, vol. 131(C), pages 297-304.
    11. Farber, Reya, 2022. "Gender, health, and labor in Thailand's medical hub," Social Science & Medicine, Elsevier, vol. 301(C).
    12. Unruh, Lynn & Rice, Thomas & Rosenau, Pauline Vaillancourt & Barnes, Andrew J., 2016. "The 2013 cholesterol guideline controversy: Would better evidence prevent pharmaceuticalization?," Health Policy, Elsevier, vol. 120(7), pages 797-808.
    13. Pollock, Anne & Jones, David S., 2015. "Coronary artery disease and the contours of pharmaceuticalization," Social Science & Medicine, Elsevier, vol. 131(C), pages 221-227.
    14. Hallin, Daniel C. & Brandt, Marisa & Briggs, Charles L., 2013. "Biomedicalization and the public sphere: Newspaper coverage of health and medicine, 1960s–2000s," Social Science & Medicine, Elsevier, vol. 96(C), pages 121-128.
    15. Timmermans, Stefan & Tietbohl, Caroline, 2018. "Fifty years of sociological leadership at Social Science and Medicine," Social Science & Medicine, Elsevier, vol. 196(C), pages 209-215.
    16. Barker, Kristin K., 2014. "Mindfulness meditation: Do-it-yourself medicalization of every moment," Social Science & Medicine, Elsevier, vol. 106(C), pages 168-176.
    17. Will, Catherine M. & Weiner, Kate, 2015. "The drugs don't sell: DIY heart health and the over-the-counter statin experience," Social Science & Medicine, Elsevier, vol. 131(C), pages 280-288.
    18. Sobo, Elisa J., 2017. "Parent use of cannabis for intractable pediatric epilepsy: Everyday empiricism and the boundaries of scientific medicine," Social Science & Medicine, Elsevier, vol. 190(C), pages 190-198.
    19. Fisher, Jill A. & Cottingham, Marci D. & Kalbaugh, Corey A., 2015. "Peering into the pharmaceutical “pipeline”: Investigational drugs, clinical trials, and industry priorities," Social Science & Medicine, Elsevier, vol. 131(C), pages 322-330.
    20. Reich, Jennifer A., 2016. "Of natural bodies and antibodies: Parents' vaccine refusal and the dichotomies of natural and artificial," Social Science & Medicine, Elsevier, vol. 157(C), pages 103-110.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:131:y:2015:i:c:p:305-312. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.